Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  Childs:
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '25941'
            Source: HGNC
          - Reference: '612839'
            Source: OMIM
          Label: tet methylcytosine dioxygenase 2
          Symbol: TET2
      Label: Refractory anemia
      ORPHAcode: '98826'
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '4171'
            Source: HGNC
          - Reference: '137295'
            Source: OMIM
          Label: GATA binding protein 2
          Symbol: GATA2
      Label: Unclassified myelodysplastic syndrome
      ORPHAcode: '98827'
  - Child:
      Genes: no data
      Label: Aregenerative anemia
      ORPHAcode: '101096'
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '612176'
            Source: OMIM
          - Reference: '29401'
            Source: HGNC
          Label: Myb like, SWIRM and MPN domains 1
          Symbol: MYSM1
      Label: Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal
        dysplasia syndrome
      ORPHAcode: '508542'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377794
    value: Clinical group
  Label: Refractory cytopenia with multilineage dysplasia
  ORPHAcode: '86836'
  ORPHApacketId: '86836'
  PURL: http://www.orpha.net/ORDO/Orphanet_86836
  Parents:
  - Parent:
    - Label: Myelodysplastic syndrome
      ORPHAcode: '52688'
  Prevalences:
    Prevalence:
    - PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Class only
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: '0.0'
  TextSection:
    Contents: Refractory cytopenias with multilineage dysplasia (RCMD) is a frequent
      subtype of myelodysplastic syndrome (MDS; see this term) characterized by 1
      or more cytopenias in the peripheral blood and dysplasia in 2 or more myeloid
      lineages.
    TextSectionType: Definition
  copyright: Orphanet (c) 2022
  creationDate: '2022-06-14 15:58:09'
  version: 1.3.16 / 4.1.7 [2022-01-26] (orientdb version)
